Telix Reports Q1 2023 Financial Results: Delivers First $100M Revenue Quarter
| Show full article |
|
This functionality is available for registred users only
|
-
Full nameTelix Pharmaceuticals Limited
-
Registration countryAustralia
-
IndustryPharmaceutical Preparation and Biotechnology
-
М/S&P/F
*** /*** /***









